Twist Bioscience Corp
TWST
Market Cap$1.85B
Close$
$42.26
30.9% upside
Current Fair Value
30.9% upsideUndervalued by 30.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.85 Billion |
|---|---|
| Enterprise Value | $1.72 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.6 |
| Beta | 2.54 |
| Outstanding Shares | 59,649,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.62 |
|---|---|
| PEG | 38.38 |
| Price to Sales | 6.46 |
| Price to Book Ratio | 4.61 |
| Enterprise Value to Revenue | 5.48 |
| Enterprise Value to EBIT | -10.07 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Twist Bioscience Corp
CEO: Emily Leproust Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...